Sánchez-Rodríguez A, Jordán RA, Bozada-Gutiérrez KE, Turrent-Carriles A

Language: Spanish
References: 15
Page: 289-292
PDF size: 205.95 Kb.

ABSTRACT

Aortitis is defined by the presence of inflammation within the aortic wall; it could be a manifestation of large-vessel vasculitis. It is often related to systemic symptoms and has several degrees of vascular damage. The most frequent etiologies currently identified include inflammatory and autoimmune factors, among which giant cell arteritis stands out (75%) and, less often, infectious and idiopathic causes. The clinical picture usually features aneurysms, dissection and disruption of the aortic wall. Diagnosis is sometimes challenging and should be complemented with image and serological markers. Medical treatment is usually effective and the surgical approach is limited to complicated cases with ruptured aneurysmatic lesions, extensive thrombosis and vascular dissections. We present the case of an 88-year male whose main complaints were abdominal pain and partial bowel obstruction as the most prominent clinical features of abdominal aortitis, documented by positron emission tomography and good initial response to treatment with glucocorticoids.

REFERENCES

1. Gornik HL, Creager MA. Aortitis. Circulation. 2008; 117 (23): 3039-3051.

2. Tezcan ME, Oztürk MA, Oner AY, Demirağ MD, Akalin T, Kaya A. Abdominal pain may dominate the scene of idiopathic aortitis. Rheumatol Int. 2011; 31 (7): 941-943.

3. Grewal GS, Leipsic J, Klinkhoff AV. Abdominal aortitis in HLA-B27+ spondyloarthritis: case report with 5-year follow-up and literature review. Semin Arthritis Rheum. 2014; 44 (3): 305-308.

4. Rojo-Leyva F, Ratliff NB, Cosgrove DM 3rd, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000; 43 (4): 901-907.

5. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990; 33 (8): 1122-1128.

6. Soravia-Dunand VA, Loo VG, Salit IE. Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis. 1999; 29 (4): 862-868.

7. Balink H, Verberne HJ, Bennink RJ, van Eck-Smit BL. A rationale for the use of F18-FDG PET/CT in fever and inflammation of unknown origin. Int J Mol Imaging. 2012; 2012: 165080.

8. Nam HY, Kim SJ, Kim IJ, Kim BS, Pak K, Kim K. The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance. Clin Nucl Med. 2010; 35 (10): 759-763.

9. Foley J, Mullan D, Mohan H, Schmidt K. Abdominal aortitis on PET CT: a case report and review of the literature. Int J Surg Case Rep. 2015; 10: 104-106.

10. Truijers M, Kurvers HA, Bredie SJ, Oyen WJ, Blankensteijn JD. In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall. J Endovasc Ther. 2008; 15 (4): 462-467.

11. Proven A, Gabriel SE, Orces C, O’Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003; 49 (5): 703-708.

12. Zehr KJ, Mathur A, Orszulak TA, Mullany CJ, Schaff HV. Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg. 2005; 79 (5): 1512-1517.

13. Espitia O, Néel A, Leux C, Connault J, Espitia-Thibault A, Ponge T et al. Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with long-term follow-up. J Rheumatol. 2012; 39 (11): 2157-2162.

14. Simon A, Subra JF, Guilpain P, Jeannin P, Pignon P, Blanchard S et al. Detection of anti-pentraxin-3 autoantibodies in ANCA-associated vasculitis. PLoS One. 2016; 11 (1): e0147091.

15. Cielik P, Hrycek A. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus. Autoimmunity. 2015; 48 (4): 242-250.